Skip to content
Friday, 20 November 2026
Inspire.News

Unveiling truth, one story at a time

Merck’s drug prolongs survival in advanced stomach, esophageal cancers in trial

Merck’s drug prolongs survival in advanced stomach, esophageal cancers in trial
Image: Arab News

Merck announced that its experimental cancer drug, sacituzumab tirumotecan, extends the survival of patients with advanced stomach and esophageal cancers compared to standard treatments.

Full story

Continue reading this story on Arab News, the publisher that reported it.

Read the full story at Arab News ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business · Middle East

See all